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Lead intoxication during development: Its effects on kidney
function and blood pressure. Exposure to lead in early life may
result in chronic renal disease in adulthood. To test this hypothe-
sis, we gave Sprague-Dawley rats, from 3 to 9 weeks of age,
either tap water or a 1% lead acetate solution, and we studied
them (in pairs) 3 and 16 weeks after exposure; that is, at 12
and 25 weeks of age. Lead-intoxicated animals failed to grow.
Their GFR's were lower compared with the matched controls
and fell between 12 and 25 weeks of age from 4.8 0.3 to 3.3
0.4 mllmin/g dry kidney wt (P < 0.01). Changes in RBF and
single nephron GFR were proportional to changes in total kidney
GFR, indicating that superficial and deep nephrons were equally
affected. The blood pressure in the lead-exposed animals studied
at 25 weeks of age was 143.2 3.7 mm Hg, a value significantly
higher than that of 130.4 3.3 observed in controls (P < 0.05).
These results demonstrate that limited exposure to lead during
development can result in progressive renal insufficiency and hy-
pertension.
Le développement de l'intoxication par le p10mb: Effets lointains
sur Ia fonction rénale et Ia pression artérielle. L'exposition au
plomb dans le jeune age peut avoir pour consequence une af-
fection rénale chronique chez l'adulte. Afin de verifier cette hy-
pothése, des rats Sprague-Dawley ont recu de l'eau du robinet
ou bien une solution a 1% d'acétate de p10mb de Ia 3è a Ia 9è
semaine de vie. Les animaux intoxiqués par le plomb ont eu un
retard de croissance, leur filtration glomérulaire était plus faible
que chez les contrôles et a diminué, entre Ia l2C et Ia 25è Se-
maine de vie, de 4,8 0,3 a 3,3 0,4 mllminlg de poids sec de
rein (P <0,01). Les modifications du debit sanguin renal et des
filtrations glomérulaires individuelles étaient proportionnelles a
celles de Ia filtration glomérulaire du rein entier, cc qui indique
que les néphrons superficiels et profonds sont egalement af-
fectés. La pression artérielle, chez les animaux exposés au
plomb, était a 143,2 3,7 mm Hg a Ia 25è semaine de vie, une
valeur significativement plus élevée que celle de 130,4 3,3 ob-
tenue chez les contrôles (P < 0,05). Ces résultats démontrent
qu'une courte exposition au plomb au cours du développement
peut avoir pour consequence une insuffisance rénale progressive
et une hypertension.
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Lead poisoning is a well-recognized entity in the
fields of pediatric and industrial medicine. Recently,
interest has surged regarding the effects of environ-
mental pollution with lead on human and animal
health [1—6]. In pediatrics, lead poisoning occupies
a unique position. Although its epidemiology, diag-
nosis, and treatment have long been known, and
advances in its prevention have been significant, it
continues to be a problem of major proportions.
The children at risk are mainly between 1 and 6
years of age, a time when pica is common. A screen-
ing program conducted in several big cities revealed
that from 8.8 to 32.9% of the children living in
dilapidated areas had blood lead concentrations
equal to or above 40 g/dl [5].
The morbidity and mortality associated with lead
poisoning remain high [7], despite the use of chelat-
ing agents such as EDTA [8, 9] and BAL (2,3-di-
mercaptopropanol) [10]. The immediate effects of
massive lead intoxication on the kidney are well
documented [11-141. Less well documented and of-
ten disputed is the contention that exposure to lead
over a limited time can result in progressive renal
disease.
Late nineteenth century physicians believed that
chronic lead intoxication caused chronic renal fail-
ure [14]. This opinion was supported by the more
recent epidemiologic studies conducted in Australia
by Nye [15] and Henderson [16, 17]. Their obser-
vations indicated that excessive exposure to lead in
early life may result in progressive renal damage and
chronic renal failure 10 to 40 years later. Similar
findings were reported from other parts of the world
[18]. The existence of a relationship between renal
disease in adulthood and lead exposure in childhood
was questioned by Tepper [19], who was unable to
find any evidence of renal involvement 20 years af-
ter a documented episode of lead intoxication. In
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Tepper's series, however, an assessment of lead ac-
cumulation was not made. Perhaps, because of an
unusually short period of exposure, little or no dep-
osition of the heavy metal in bone or other organs of
the body occurred. In a similar survey, Chisolm [20]
demonstrated that patients without evidence of re-
nal involvement had no increase in urinary lead ex-
cretion in response to administration of EDTA.
Numerous experimental studies have duplicated
and expanded the clinical observations of acute lead
intoxication [2 1—26]. Some have attempted to repro-
duce chronic lead intoxication in adult animals [27—
33]. No study, however, has addressed the question
whether excessive exposure to lead for a limited pe-
riod of time during early life may result in progres-
sive renal insufficiency. Our purpose was to exam-
ine this question.
Methods
Three-week-old littermates (Sprague-Dawley rats)
were paired according to weight and sex, and were
randomly assigned to either an experimental group,
which received 1% lead acetate as a drinking solu-
tion, or to a control group, which received tap
water. Lead exposure was limited to the 6-week pe-
riod corresponding to 3 to 9 weeks of age. All rats
were allowed free acess to rat chow (Ralston Purina
Co., New Jersey). Each pair was studied either at
12 or at 25 weeks of age.
The rats were anesthetized with mactin® (10 mgI
100 g body wt, i.p.) and then were placed on a ther-
mostatically controlled table. Polyethylene cath-
eters (PE-50; Clay Adams Co.) were inserted into
the right jugular vein for injection of lissamine
green, the right femoral artery for blood sampling,
and the right femoral vein for infusion of fluids. The
bladder was exposed through a suprapubic incision.
Two PE-50 catheters were positioned: one in the
bladder, the other in the left ureter. The left kidney
was prepared for micropuncture by a previously de-
scribed method [34]. Isotonic saline in a volume
equivalent to 0.5 ml! 100 g body wt was given imme-
diately after surgical preparation of the animal, and
a 0.9% saline solution containing 25 Ci!ml of 14C-
inulin (New England Nuclear) was infused there-
after at a rate of 0.5 mL'hr/lOO g body wt. Following
a 45-mm equilibration period, two to three urine col-
lections, each of 30 mm's duration, were obtained,
and timed collections of proximal tubular fluid
were performed. Blood samples were withdrawn,
and measurements of arterial blood pressure were
made at the midpoint of each period. These samples
served for the measurements of GFR and single
nephron GFR (SNGFR). The radioactivity in blood,
urine, and tubular fluid was measured in a beta scin-
tillation counter (Intertechnique SL-40).
At the end of the experiment, the rats were killed,
and their kidneys were removed rapidly, decapsu-
lated, blotted, and weighed. Dry kidney weight was
measured after 24 hours of dessication at 100° C. In
each of 14 animals, one kidney was cut into halves.
One half was fixed in 10% formalin and processed
for light microscopy; the other was fixed in 1.5%
glutaraldehyde and embedded in epoxy by standard
methods. Ultrathin sections were stained with aque-
ous lead citrate and ethandic uranyl nitrate and ex-
amined by electron microscopy.
The RBF and its intrarenal distribution were de-
termined in a separate group of rats with a mean age
of 12 weeks. The surgical preparation of these rats
was similar to that described above, except that the
left kidney was not isolated for micropuncture, and
a silastic catheter (0.9-mm O.D., Dow Corning) was
introduced into the left ventricle via the right carot-
id artery. This served for measurements of blood
pressure and for the injection of a bolus of 0.2 to 0.3
ml of 0.9% saline containing 30,000 to 40,000 855r-
labeled microspheres with diameters of 15 Sp.
Calculations of RBF were made from a reference
sample of blood [35] collected from the femoral ar-
tery by a pump set to withdraw at a rate of 1 mllmin.
The collection rate and duration that we used (10
sec before, to continue for 50 sec after, the injection
of microspheres) were chosen to minimize the ef-
fect of recirculation and to decrease the error in de-
termining the volume of the reference sample. The
rats were then killed and their kidneys removed,
blotted, and weighed. RBF was calculated accord-
ing to the formula:
counts per kidney X 1 mllmin
counts per reference sample
Measurements of the intrarenal blood flow distribu-
tion were made by a method previously described
[36], except that three rather than four cortical sec-
tions were obtained. A midlongitudinal section, ap-
proximately 1.5-mm thick, was cut from each kid-
ney. Two or three approximately 5-mm broad seg-
ments with corticomedullary borderlines parallel to
the surface were selected from each midsection, ex-
cluding medullary rays as carefully as possible. The
cortex was separated from the medulla just below
the arcuate vessels and was divided into three
equally thick zones by cuts paralleling the outer sur-
face and the corticomedullary borderline.
The concentration of lead in whole blood was
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measured in 19 rats by atomic absorption (Biosci-
ence Laboratories, Pasadena, California).
Student's t test was used to determine the signifi-
cance of differences between the observations made
in the two age groups. Differences between the con-
trol and the experimental animals of each pair were
tested for significance by Student's t test for paired
observations [39].
Results
During the last half of the period of exposure to
lead (6 to 9 weeks of age), the blood lead concentra-
tion was 155.0 (sEM) 37.5 pJdl (N = 6), falling to
55.8 8.4 jxg/dl (N = 6) by 12 weeks (P <0.05) and
to 23.5 4.3 p.g/dl(N = 4) by 25 weeks of age (P <
0.05). The blood lead concentration in the control
rats was 17.0 1.5 .tg/dl (N 3), a value not
significantly different from that found in the 25-
week-old experimental rats (P > 0.2).
As expected, control rats studied at 25 weeks of
age weighed substantially more than those exam-
ined at 12 weeks (P <0.01, Table 1). In contrast, no
significant difference in body weight was demon-
strable between the two age groups of rats exposed
to lead (P > 0.3). At both ages, experimental rats
weighed less than their paired controls (P <0.001,
Fig. 1).
Neither dry kidney weight nor renal water con-
tent changed between 12 and 25 weeks of age in ei-
ther lead-exposed or control rats. Analysis of the
paired data, however, demonstrated that the renal
water content was 1.5 0.5% higher in the rats ex-
posed to lead (P <0.01) than it was in controls (Fig.
2).
300
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Fig. 1. Body weight of 12-week-old (.) and 25-week-old (•) rats
exposed to lead during early postnatal life and of their respective
paired controls (open symbols) (P <0.001).
Table 1. Morphologic and functional characteristics of control rats and rats exposed to leada
Renal H20 GFR/dry
Age Body wt Dry kidney wt content GFR kidney wt SNGFR BP
weeks g g % ,nl/min mi/minig ni/mm mm Hg
Control rats
12 394.3 0.33 75.7 1.9 5.7 73.6 126.5
±18.1 ±0.01 ±0.3 ±0.1 ±0.5 ±4,4 ±4.0(N = 10) (N = 6) (N = 6) (N = 5) (N = 5) (N = 5) (N = 9)
25 470.6 0.35 76.8 1.6 4.7 74.8 130.4
±30.8 ±0.02 ±0.5 ±0.1 ±0.2 ±4.4 ±3.3(N = 5) (N = 5) (N = 5) (N = 5) (N = 5) (N = 5) (N = 5)
P <0.05 >0.3 <0.05 >0.1 >0.1 >0.8 >0.5
Rats exposed to lead
12 313.7 0.29 77.2 1.4 4.8 51.2 125.2
±22.9 ±0.03 ±0.8 ±0.2 ±0.3 ±3.8 ±5.0(N = 10) (N = 6) (N = 6) (N 6) (N = 6) (N = 6) (N = 9)
25 346.1 0.30 78.3 1.0 3.3 49.9 143.2
±19.2 ±0.03 ±0,6 ±0.1 ±0.4 ±3.4 ±3.7
(N=5) (N=5) (N=5) (N=5) (N=5) (N=5) (N=5)
Values are the means ± SEM.
P >0.3 >0.6 >0.3 >0.1 <0.01 >0.7 <0.05
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GFR, expressed in absolute values, did not
change significantly between 12 and 25 weeks of age
either in the control (1.9 0.1 at 12 weeks vs. 1.6
0.1 mI/mm at 25 weeks, P > 0.3) or the experimen-
tal rats (1.4 0.2 and 1.0 0.1 mI/mm, respective-
ly, P > 0.1). Analysis of the paired data, however,
demonstrated that the GFR in experimental rats was
0.62 0.2 mI/mm less than it was in controls (P
< 0.005). There was also a lack of a significant
change in the GFR of control rats in the interval
between 12 and 25 weeks when expressed relative
to dry kidney weight (P > 0.1). A significant fall in
GFR relative to dry kidney weight was documented
in the experimental rats (P < 0.01, Table 1). This
resulted from the combined effects of a small but
statistically nonsignificant increase in dry kidney
weight (also observed in the control rats) and a de-
crease in absolute GFR. Analysis of the paired data
demonstrated that the GFR of experimental rats
was 1.2 0.3 mllmin/g dry kidney wt less than the
value for controls (P < 0.01, Fig. 3).
Single superficial nephron GFR did not change
between 12 and 25 weeks of age either in control or
in experimental rats (Table 1).' SNGFR was lower,
however, in lead-exposed rats than it was in control
rats (P < 0.005, Fig. 4). Lead-intoxicated rats had
lower rates of RBF than did control rats 5.0 0.7
vs. 8.2 1.3 mllmin, respectively (P < 0.02, Table
2), but the intrarenal distribution of blood flow was
similar in the two groups. The same relationships
were observed when the results were corrected for
kidney weight.
The mean ratios of experimental to control GFR,
SNGFR, and RBF were compared with each other
to discern if lead intoxication affected all the neph-
rons uniformly, and to assess whether or not the
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Fig. 2. Renal water content expressed as percent of kidney
weight (P <0.01). For symbols, see legend to Fig. 1.
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'The values of SNGFR found in this study are higher than
those reported previously in the rat [38]. The rats studied by us,
however, were substantially older and larger than those usually
used for micropuncture. Potter et al [39] have shown that in the
rat GFR increases continuously between 3 weeks and 3 months of
age. In their study, the largest rats weighed 381 4 g and had a
mean GFR of 1.6 0.1 mI/mm. This value is quite similar to that
observed by us in the 12-week-old control rats (1.9 0.1 mI/mm)
which weighed 394 18 g. Assuming a nephron population of
25,000 to 35,000 [40], we can calculate the average SNGFR to be
between 54 and 76 nI/mm. The SNGFR observed by us (73.6
4.4 nI/mm) falls within this range. In contrast, the older rats in
the experimental groups weighed 346 19 g and had a whole
kidney filtration rate of only 1.0 0.1 mI/mm. This value is sub-
stantially less than 1.5 0.1 mI/mm observed by Potter et al in
rats weighing 333 5.6 g [38]. Assuming a full nephron popu-
lation, the mean SNGFR would fall between 43 and 60 nI/mm.
The mean of 49.9 3.4 nI/mm observed by us falls toward the
lower limit of this range.
2j-
Fig. 3. GFR observed in lead-exposed and control rats (P <0.01).
For symbols, see legend to Fig. 1.
changes in filtration rate were proportional to those
in RBF. These ratios (0.67 0.08 for GFR, 0.76
0.06 for SNGFR, and 0.58 0.03 for RBF) did not
differ significantly from each other when tested by
analysis of variance (P > 0.8).
Mean systemic blood pressure did not change in
control animals (P > 0.5) between 12 (126 4.8
mm Hg) and 25 weeks of age (130 3.3 mm Hg,
Fig. 5). In experimental animals, however, a signifi-
cant (P <0.05) rise in blood pressure, from 125.2
5.0 to 143.2 3.7 mm Hg, was observed during the
same period. Moreover, analysis of variance dem-
onstrated that the blood pressure in the 25-week-old
experimental rats was higher than that found in all
other groups (P <0.05).
Histopathologic examination of the kidneys
showed irregular tubular dilatation and moderate
epithelial cell abnormalities in the experimental rats
killed at 12 weeks. The cells of the proximal con-
voluted tubules contained large, vesicular, and
pleomorphic nuclei; typical intranuclear inclusions
were confirmed by electron microscopy. Focal
tubular disruption and minimal interstitial inflam-
mation were present in one rat. In none of the speci-
mens was there any evidence of glomerular abnor-
mality, either by light or electron microscopy, and
electron microscopy of one specimen did not reveal
cytoplasmic abnormality. One rat killed at 25 weeks
had moderately severe tubular damage with at-
rophy, accompanied by interstitial fibrosis and in-
flammation. Cellular changes were more severe
than they were at 12 weeks, with cytoplasmic baso-
philia and more striking nuclear changes. The gb-
meruli were histologically normal. These findings
are similar to those reported by other investigators
in animals exposed to lead for a similar length of
time [22, 23].
Discussion
The toxic effects of heavy metals, particularly
lead, have been extensively studied, There is agree-
ment about some of the complications, but there is
controversy about others. For instance, there is a
consensus that the process of growth is impaired
during exposure to lead [41, 42], particularly so
when exposure occurs in the perinatal period [41,
43—45]. In contrast, considerable debate persists re-
garding the effect of lead intoxication on renal func-
tion.
Our measurements of body weight are consistent
with those reported by others, demonstrating last-
ing effects of lead on the growth process. During 13
weeks of observation, no significant gain in body
weight was observed in experimental rats, whereas
the control rats grew substantially.
Reduced rates of GFR and RBF have been re-
ported in the human [46] but have not been found in
the adult rat exposed to lead [32]. The discrepancy
between these data and ours might result from dif-
Table 2. Renal blood flow (RBF) and intrarenal distribution of RBF in control rats and rats exposed to lead from 3 to 9 weeks of agea
RBF
Intrarenal distribution of RB F. %
mI/mm
nl/rninIg
wet kidney wt Outer cortex Mid cortex Deep cortex
Lead 5.0 0.7 3.9 0.5 76.0 3.1 21.1 2.5 2.8 0.6
Control 8.2 1,3 6.1 0.5 76.7 2.9 19.6 2.3 3.6 0.9
P <0.005 <0.005 >0.6 >0.3 >0.2
Values are means SEM.
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Fig. 4. Values o,fSNGFR in control rats and rats exposed to lead
3 and 16 weeks prior to the measurements. Each point represents
the mean of two to five measurements obtained on one rat. The
difference between the pairs is significant (P < 0.005). For sym-
bols, see legend to Fig. 1.
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Age, weeks
Fig. 5. Mean arterialblood pressure in control and experimental
rats 3 and /6 weeks after the cessation of lead ad,ninistrat ion.
The value observed at 25 weeks is significantly higher than all
others (P < 0.05).
ferences in the severity of the exposure, the age
when it occurred [41, 47], or both. Our studies dem-
onstrate that young rats subjected to lead for a limit-
ed time developed sequelae, giving credence to the
hypothesis that the age at the time of exposure in-
fluences the effect of the lead on the kidney. The
possibility exists that the differences in GFR be-
tween experimental and control rats are due to the
general effect of lead on growth. Against this hy-
pothesis is the observation that differences in both
total kidney GFR and single nephron GFR were ob-
served not only when corrections were made for
kidney weight but also when the results were ex-
pressed per unit of body weight (P < 0.01). This
demonstrates that the lead intoxication affected re-
nal function to a larger degree than would be ex-
pected solely from an impairment of renal or body
growth. Further evidence in favor of a selective ef-
fect of lead on the kidney is provided by the fact
that GFR per gram of dry kidney weight continued
to fall after the exposure to the toxin has ceased.
The decrease in renal function was not associated
with discernible changes in the histologic appear-
ance of the glomerulus. In one rat studied histologi-
cally at 25 weeks, however, there was an indication
that tubulointerstitial disease may have been re-
sponsible for the fall in renal function. How-
ever, since the proportionality between GFR
and RBF was maintained, an alternative hypo-
thesis is that the primary factor was a decrease in
RBF, possibly induced by the effect of lead on the
renal vasculature [48]. It is also possible that the
reduction in GFR was triggered by an increase in
delivery of solute to the distal segments of the neph-
ron, consequent to proximal tubular damage [22].
The experimental studies concerning the effect of
lead intoxication on systemic blood pressure have
generated conflicting results. Diaz-Rivera and Horn
[28] and Griffith and Lindauer [31] reported the con-
sistent development of hypertension in the rat during
lead ingestion, whereas Pardoe [32] and Tange, Hay-
ward, and Bremner [33] failed to find significant ele-
vations of blood pressure in the same species, under
similar circumstances. No elevation in blood pres-
sure was found in a single dog experiment during
lead exposure [29]. It should be noted, however,
that in each of these studies exposure to lead oc-
curred during adult life, and in all but one, there was
no control group. Similar inconsistencies can be
found in the liteature pertaining to human subjects.
Lilis et al [49], Radosevic et al [50], Beevers et al
[51], Cramer and Dahlberg [52], and Mayers [53]
noted elevated blood pressure in their patients ex-
posed to lead, whereas Belknap [54] and Jones [55]
did not observe such a phenomenon. This discrep-
ancy might be explained by the difference in the
length of followup. Cramer et al [52] and Beevers et
al [51] suggested that hypertension occurs long after
the initial exposure to lead. In retrospective obser-
vations on more than 400 patients who had been
hospitalized in childhood with the diagnosis of lead
intoxication, Henderson [56] found that more than
25% died 10 to 40 years later from chronic nephritis
and hypertension; close to 5% of those surviving
had hypertension. Our data demonstrate that ad-
ministration of lead to experimental animals is in-
deed associated with the development of hyper-
tension and that this complication occurs after a pe-
riod of latency, i.e. between 3 and 16 weeks after
cessation of exposure to lead. The mechanism of
how hypertension is produced remains a matter of
speculation. Lead was reported to induce vaso-
constriction [48]. Such an effect is consistent with
the proportional reductions in SNGFR, GFR, and
RBF observed by us, but it is inconsistent with the
observations that plasma renin activity is depressed
in patients with chronic lead intoxication [42, 57],
because a reduction in RBF would be expected to
stimulate synthesis and release of renin. Alterna-
tively, it is possible that the hypertension might be
volume dependent. In the absence of precise mea-
surements of plasma and extracellular fluid vol-
umes, the high water content of certain organs ob-
served by us as well as others [58] in subjects ex-
posed to lead might be construed to support this
Contro'
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assumption. By analogy to other experimental mod-
els [59], it is reasonable to consider the possibility
that the elevation in blood pressure initially might
be renin dependent, only to become volume depen-
dent in the chronic state.
Unlike adult rats [32], young rats exposed to lead
for a limited period of time develop important se-
quelae. This difference may be explained by a high
sensitivity of rapidly multiplying cells to noxious
agents. The pathologic manifestations consequent
to lead intoxication, such as renal impairment and
hypertension, may become overt long after the ex-
posure has ceased. Which of these disturbances has
a greater impact on prognosis remains to be deter-
mined.
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